Late-breaking TAILORx data to be presented at ESMO Congress 2019

[News]

New data from TAILORx, the federally funded, phase three clinical trial, will be presented as late-breaking information at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain.

More... (https://www.news-medical.net/news/20190926/Late-breaking-TAILORx-data-to-be-presented-at-ESMO-Congress-2019.aspx)